Drugs / EMLA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02318654 Comparator | Dec 2014 → Dec 2027 expected | — | Northwestern University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EMLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02318654 ↗ |
| Route | Topical | “Topical EMLA will be applied approximately 2 mm thick to the randomized axilla” NCT02318654 ↗ |